Tobii AB (publ) (STO:TOBII)
Sweden
· Delayed Price · Currency is SEK | Market Cap | 513.23M |
| Revenue (ttm) | 834.00M |
| Net Income (ttm) | -217.00M |
| Shares Out | 235.00M |
| EPS (ttm) | -0.93 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 601,642 |
| Average Volume | 1,250,210 |
| Open | 2.200 |
| Previous Close | 2.188 |
| Day's Range | 2.150 - 2.222 |
| 52-Week Range | 1.300 - 7.420 |
| Beta | 0.48 |
| RSI | 61.85 |
| Earnings Date | Apr 10, 2026 |
About Tobii AB
Tobii AB (publ) develops and sells eye-tracking technology and solutions in Sweden, Europe, Middle East, Africa, the United States, and internationally. The company offers Tobii Pro Glasses 3, a wearable eye tracker; screen based eye trackers, including Tobii Pro spectrum, Tobii Pro fusion, and Tobii Pro Spark; and motion capture, protective and corrective lenses, mobile testing accessories, tripod stands, shimmers, stim trackers, and chin rest accessories. It also provides Tobii Pro Lab, an eye tracking software for multimodal research solutio... [Read more]
Financial Performance
In 2025, Tobii AB's revenue was 834.00 million, a decrease of -2.68% compared to the previous year's 857.00 million. Losses were -217.00 million, 22.6% more than in 2024.
Financial StatementsNews
Tobii AB Earnings Call Transcript: Q4 2025
Q4 2025 saw weak revenue and results due to global headwinds and currency effects, but significant cost reductions and a one-time DMS licensing deal improved free cash flow. Major non-cash write-offs impacted EBIT, and financing risks remain a key focus for management.
Tobii AB Earnings Call Transcript: Q3 2025
Q3 2025 saw weak sales and profitability declines, but major milestones in AutoSense, including regulatory approvals and industry validation, position the segment for future growth. Cost reductions and strategic reviews are underway to address near-term financing needs.
Tobii AB Earnings Call Transcript: Q2 2025
Q2 saw a 41% rise in net sales and a SEK 24 million positive EBIT, driven by cost savings and a major Dynavox deal. Product launches and EU homologation for single-camera DMS/OMS strengthened market position, while free cash flow improved by nearly SEK 200 million year-over-year.
Tobii AB Earnings Call Transcript: Q1 2025
Best-ever Q1 with first positive EBIT, 23% net sales growth, and improved cash flow. Cost reductions and strategic divestments strengthened financials, while all segments contributed to profitability. AutoSense segment advanced with regulatory milestones and is set for production ramp in H2 2025.
Tobii AB Earnings Call Transcript: Q4 2024
Record EBIT and improved margins in Q4, driven by cost reductions and acquisition synergies. Autosense segment showed strong growth, with new design wins and over 600,000 vehicles on the road, while further cost actions and potential divestments are planned for 2025.
Tobii AB Earnings Call Transcript: Q3 2024
Q3 2024 saw 40% net sales growth driven by the FotoNation acquisition, significant EBIT improvement, and strong progress in automotive sensing. Cost reduction initiatives are on track, with further one-off costs expected in Q4 and a lower cost base anticipated for 2025.
Tobii AB Earnings Call Transcript: Q2 2024
Net sales rose 8% year-over-year, driven by the FotoNation acquisition, while organic growth declined. Aggressive cost reduction measures are underway to address high cash burn and weaker demand, with a focus on achieving positive free cash flow and improved margins by 2026.
Tobii launches Tobii Nexus - webcam eye tracking for integration into any device or application
A software-only integration platform that enables eye tracking capabilities for devices with a webcam, helping developers create smarter abilities and interactivity within their applications - for ...
Tobii launches Glasses Explore - making human behavioral insights more accessible
An intuitive and easy to use software that opens the world of human behavioral insights to a wider audience. STOCKHOLM , June 10, 2024 /PRNewswire/ -- Tobii, the global leader in eye tracking and pion...